Investor FAQ

Investor FAQ

Show all

Our common stock is listed on the Nasdaq Global Market under the symbol ZGNX. Our CUSIP number is 98978L105.
The transfer agent and registrar for our common stock is American Stock Transfer & Trust Company, located at 59 Maiden Lane, New York, NY 10038.
Zogenix’ fiscal year ends on December 31st.
We were incorporated in Delaware on May 11, 2006 as SJ2 Therapeutics, Inc. We commenced our operations on August 25, 2006 and changed our name to Zogenix, Inc. on August 28, 2006.
You may submit a request for information by filling out our Information Request form.
You may contact investor relations via email at ir@zogenix.com.
No. We have never declared or paid any cash dividends on our capital stock and do not anticipate paying any cash dividends in the foreseeable future.
We have retained Ernst & Young LLP, an independent registered public accounting firm, as our independent auditors.
Latham & Watkins LLP (12636 High Bluff Drive, Suite 400, San Diego, CA 92130, (858) 523-5400) provides Zogenix legal counsel.
As of November 2017, Zogenix has 65 full-time employees.
Zogenix’ officers and directors can be found in the "About Zogenix" section of the Web site.
5858 Horton Street, Suite 455, Emeryville, CA 94608
Zogenix does not currently offer a direct stock purchase plan. Shares can be purchased through a broker of your choice.
We provide up-to-date information about the performance of Zogenix stock on in the Stock Info section of our investor relations site.
Please review the latest SEC filings, which are available on ir.zogenix.com and at www.sec.gov.
You will need to contact the broker from whom you purchased your shares.
We plan to issue a press release and hold a conference call each quarter to discuss financial results. At least one week prior, we will issue a press release announcing the date and time of our call, with information for interested participants to access our conference call and webcast. You can also visit our Webcasts & Events page
You can listen to our quarterly webcasts live by visiting the Webcast and Events page in the Investor Relations section of our website. All webcasts will be archived for one month following each quarterly call.
Archived webcasts are available in the investor relations section of our website on the Webcasts and Events page. Alternatively, a replay of our quarterly earnings conference calls are made available for one week following the live event. Look for the quarterly earnings press release located on our News Releases page for replay dial-in information.
Our SEC filings are available on our investor relations site, and at www.sec.gov
Our quarterly and annual reports are available for download (.pdf) in the SEC Filings section of our investor relations site. If you would like to request a paper copy of the report by mail, you may send your request to ir@zogenix.com.
You may choose to set up email alerts through ir.zogenix.com.
Please visit the Contact Us page on the Company Web site where an email address and contact form is provided. Additionally, Zogenix can be reached by calling (858) 259-1165.
LifeSci Advisors LLC is Zogenix’ investor relations agency of record. For additional information please contact: Andrew McDonald, 646-597-6987 or Andrew@lifesciadvisors.com.
Please review the latest SEC filings, which are available on ir.zogenix.com and at www.sec.gov.
You may submit a question by filling out our Information Request form.